Follow
Kai Januschowski
Kai Januschowski
Mount St. Peter Eye Clinic Trier, University eye hospital Tuebinge
Verified email at med.uni-tuebingen.de - Homepage
Title
Cited by
Cited by
Year
The cross-linked biopolymer hyaluronic acid as an artificial vitreous substitute
C Schramm, MS Spitzer, S Henke-Fahle, G Steinmetz, K Januschowski, ...
Investigative ophthalmology & visual science 53 (2), 613-621, 2012
1152012
Comparative toxicity and proliferation testing of aflibercept, bevacizumab and ranibizumab on different ocular cells
S Schnichels, U Hagemann, K Januschowski, J Hofmann, ...
British Journal of Ophthalmology 97 (7), 917-923, 2013
792013
Long-term results after artificial iris implantation in patients with aniridia
A Rickmann, P Szurman, K Januschowski, M Waizel, MS Spitzer, ...
Graefe's Archive for Clinical and Experimental Ophthalmology 254, 1419-1424, 2016
572016
Rate and timing of spontaneous resolution in a vitreomacular traction group: should the role of watchful waiting be re-evaluated as an alternative to ocriplasmin therapy?
S Dimopoulos, KU Bartz-Schmidt, F Gelisken, K Januschowski, ...
British Journal of Ophthalmology 99 (3), 350-353, 2015
572015
Electrophysiological effects of Brilliant Blue G in the model of the isolated perfused vertebrate retina
M Lüke, K Januschowski, J Beutel, C Lüke, S Grisanti, S Peters, ...
Graefe's Archive for Clinical and Experimental Ophthalmology 246, 817-822, 2008
572008
Efficacy of two different thiol-modified crosslinked hyaluronate formulations as vitreous replacement compared to silicone oil in a model of retinal detachment
S Schnichels, N Schneider, C Hohenadl, J Hurst, A Schatz, ...
PLoS One 12 (3), e0172895, 2017
482017
The retinal tolerance to bevacizumab in co-application with a recombinant tissue plasminogen activator
M Lüke, K Januschowski, M Warga, J Beutel, M Leitritz, F Gelisken, ...
British journal of ophthalmology 91 (8), 1077-1082, 2007
472007
Retinal toxicity of medical devices used during vitreoretinal surgery: a critical overview
K Januschowski, C Irigoyen, JC Pastor, GK Srivastava, MR Romano, ...
Ophthalmologica 240 (4), 236-243, 2018
462018
Novel liquid bubble dissection technique for DMEK lenticule preparation
P Szurman, K Januschowski, A Rickmann, LJ Damm, KT Boden, N Opitz
Graefe's Archive for Clinical and Experimental Ophthalmology 254, 1819-1823, 2016
422016
Micro-invasive 360-degree suture trabeculotomy after successful canaloplasty–one year results
AM Seuthe, K Januschowski, P Szurman
Graefe's Archive for Clinical and Experimental Ophthalmology 254, 155-159, 2016
392016
Measuring wearing times of glasses and ocular patches using a thermosensor device from orthodontics
K Januschowski, TE Bechtold, TC Schott, MS Huelber‐Januschowski, ...
Acta ophthalmologica 91 (8), e635-e640, 2013
382013
Ex vivo biophysical characterization of a hydrogel-based artificial vitreous substitute
K Januschowski, S Schnichels, J Hurst, C Hohenadl, C Reither, ...
PLoS One 14 (1), e0209217, 2019
372019
Mycophenolic acid in the treatment of birdshot chorioretinopathy: long-term follow-up
D Doycheva, H Jägle, M Zierhut, C Deuter, G Blumenstock, U Schiefer, ...
British Journal of Ophthalmology 99 (1), 87-91, 2015
362015
Investigation of a novel implantable suprachoroidal pressure transducer for telemetric intraocular pressure monitoring
S Mariacher, M Ebner, K Januschowski, J Hurst, S Schnichels, P Szurman
Experimental eye research 151, 54-60, 2016
352016
Evaluating retinal toxicity of a new heavy intraocular dye, using a model of perfused and isolated retinal cultures of bovine and human origin
K Januschowski, S Mueller, MS Spitzer, C Schramm, D Doycheva, ...
Graefe's Archive for Clinical and Experimental Ophthalmology 250, 1013-1022, 2012
332012
Modified canaloplasty with suprachoroidal drainage versus conventional canaloplasty—1-year results
AM Seuthe, C Ivanescu, S Leers, K Boden, K Januschowski, P Szurman
Graefe's Archive for Clinical and Experimental Ophthalmology 254, 1591-1597, 2016
322016
Preservative-free triamcinolone acetonide injectable suspension versus “traditional” triamcinolone preparations: impact of aggregate size on retinal biocompatibility
MS Spitzer, T Mlynczak, M Schultheiss, K Rinker, E Yoeruek, ...
Retina 31 (10), 2050-2057, 2011
322011
Immunomodulatory therapy with tumour necrosis factor α inhibitors in children with antinuclear antibody-associated chronic anterior uveitis: long-term results
D Doycheva, M Zierhut, G Blumenstock, N Stuebiger, K Januschowski, ...
British Journal of Ophthalmology 98 (4), 523-528, 2014
312014
Toxic effects of melphalan, topotecan and carboplatin on retinal pigment epithelial cells
D Süsskind, U Hagemann, M Schrader, K Januschowski, S Schnichels, ...
Acta ophthalmologica 94 (5), 471-478, 2016
302016
Investigating the biocompatibility of two new heavy intraocular dyes for vitreoretinal surgery with an isolated perfused vertebrate retina organ culture model and a retinal …
K Januschowski, S Mueller, MS Spitzer, J Hoffmann, C Schramm, ...
Graefe's Archive for Clinical and Experimental Ophthalmology 250, 533-545, 2012
292012
The system can't perform the operation now. Try again later.
Articles 1–20